Geron Corporation

Geron Corporation is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Geron Corporation is not a good value stock. Geron Corporation is not very popular among insiders. Geron Corporation is a mediocre stock to choose.
Log in to see more information.
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in...
GERN Fundamental Data by TradingView

News

Bank of New York Mellon Corp Grows Stock Holdings in Geron Co. (NASDAQ:GERN)
Bank of New York Mellon Corp Grows Stock Holdings in Geron Co. (NASDAQ:GERN)

Ticker Report Bank of New York Mellon Corp increased its stake in Geron Co. (NASDAQ:GERN - Free Report) by 26.0% during the 2nd quarter, according to its most recent filing with the Securities Exchange...\n more…

Geron (NASDAQ:GERN) Now Covered by Leerink Partners
Geron (NASDAQ:GERN) Now Covered by Leerink Partners

Ticker Report Stock analysts at Leerink Partners began coverage on shares of Geron (NASDAQ:GERN - Get Free Report) in a report released on Monday, MarketBeat reports. The firm set an "outperform" rating and a...\n more…

Leerink Partners Begins Coverage on Geron (NASDAQ:GERN)
Leerink Partners Begins Coverage on Geron (NASDAQ:GERN)

Zolmax Equities researchers at Leerink Partners assumed coverage on shares of Geron (NASDAQ:GERN - Get Free Report) in a research report issued to clients and investors on Monday, MarketBeat.com reports...\n more…

Geron (NASDAQ:GERN) Upgraded at Leerink Partnrs
Geron (NASDAQ:GERN) Upgraded at Leerink Partnrs

Ticker Report Leerink Partnrs upgraded shares of Geron (NASDAQ:GERN - Free Report) to a strong-buy rating in a research report released on Monday morning, Zacks.com reports. A number of other analysts have also...\n more…

Geron Corporation Announces Appointment of Jim Ziegler as Chief Commercial Officer
Geron Corporation Announces Appointment of Jim Ziegler as Chief Commercial Officer

Business Wire Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, announced the appointment of Jim Ziegler as Executive...\n more…

Geron names Jim Ziegler CCO
Geron names Jim Ziegler CCO

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…